Schroder Investment Management Group’s Collegium Pharmaceutical COLL Stock Holding History

Schroder Investment Management Group’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-45,652	Closed	-$853K	–	1400
2021 Q4	$853K	Sell	45,652 -2,657	-6%	-$51.8K	﹤0.01%	1056
2021 Q3	$954K	Sell	48,309 -17,195	-26%	-$372K	﹤0.01%	1109
2021 Q2	$1.55M	Buy	65,504 +3,819	+6%	+$88.2K	﹤0.01%	1069
2021 Q1	$1.46M	Sell	61,685 -13,449	-18%	-$319K	﹤0.01%	1069
2020 Q4	$1.5M	Sell	75,134 -14,587	-16%	-$285K	﹤0.01%	1051
2020 Q3	$1.9M	Sell	89,721 -10,035	-10%	-$181K	﹤0.01%	896
2020 Q2	$1.75M	Buy	99,756 +23,525	+31%	+$461K	﹤0.01%	844
2020 Q1	$1.34M	Buy	+76,231	New	+$1.57M	﹤0.01%	864
2019 Q3	–	Sell	-19,443	Closed	-$256K	–	1283
2019 Q2	$256K	Buy	+19,443	New	+$260K	﹤0.01%	1059

Other funds holding COLL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Schroder Investment Management Group's COLL Position: Q1 2022 in Review

Schroder Investment Management Group sold out of Collegium Pharmaceutical (COLL) in Q1 2022, closing a stake of 45,652 shares — an estimated $853K sold.

Schroder Investment Management Group first reported a position in COLL in Q2 2019 and held it in 9 quarters. The position peaked at $1.9M in Q3 2020. 172 funds tracked by Wall St. Rank hold COLL as of Q1 2022.

Schroder Investment Management Group reported no remaining Collegium Pharmaceutical position as of Q1 2022 after selling out during the quarter.
Schroder Investment Management Group sold 45,652 Collegium Pharmaceutical shares in Q1 2022, an estimated $853K.
Schroder Investment Management Group first reported a position in Collegium Pharmaceutical in Q2 2019 and held it in 9 quarters.
Schroder Investment Management Group's Collegium Pharmaceutical position peaked at $1.9M in Q3 2020.
172 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2022.

Based on Schroder Investment Management Group's 13F filing for Q1 2022, filed 16 May 2022.